OUR COMPANY

At Catalyst OrthoScience, our goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients. Catalyst OrthoScience was founded by a board-certified orthopedic surgeon and is comprised of a team of biomedical industry professionals with more than 100 years of combined medical device experience.

The Catalyst CSR Total Shoulder System is the result of the visionary insight of Steven Goldberg, M.D., a fellowship-trained orthopedic surgeon and shoulder specialist, who devised the next generation, higher precision, less-invasive total shoulder solution with a greatly simplified method of implant placement.

The key design elements of this new system are 1) to preserve as much of the patient’s bone as possible, 2) to create implants to better mimic the natural elliptical shape of the human shoulder, and 3) to provide a system that greatly improves the consistency and reproducibility of the operation.

In 2011, Dr. Goldberg began development of the revolutionary implant with the new shape and created prototypes using a 3-D printing service. Armed with two U.S. provisional patents and positive feedback from several prominent shoulder specialists, the Catalyst CSR Total Shoulder System was born.

 

Leadership

Robert M. Kaufman, Chairman & Chief Executive Officer

Robert (Bob) Kaufman is the Chairman and Chief Executive Officer of Catalyst Orthoscience. Prior to that he was Senior Vice President in charge of virtually all areas of Outcome Sciences, the premier Phase IV Clinical Research Organization of the world, sold successfully to Quintiles Corporation. Before Outcome Sciences he was President and CEO of both MedEView Corporation, a healthcare technology company sold successfully to a subsidiary of HealthSouth Corporation and Carematrix, a public senior housing company  He has been investing in and advising medical device companies including Medtronic and Johnson & Johnson healthcare divisions for over 20 years.  His involvement in all aspects of healthcare dates back to 1984.  Bob graduated with a Masters Degree in Business from Cornell University and a Bachelor of Science from Colby College.

Stephen Herrington, Chief Operating Officer

Stephen Herrington is the Chief Operating Officer of Catalyst OrthoScience.  Mr. Herrington is a seasoned medical device executive with extensive experience with R&D, Operations and Business Development. Prior to joining Catalyst, Mr. Herrington was the Vice President of Research and Development at Biomet 3i. He was previously Vice President of Operations Strategy/Engineering Services at Biomet. Mr. Herrington served as Vice President of R&D at both Arthrex and Walter Lorenz Surgical.  Mr. Herrington began his engineering career with Zimmer.

Rod Allen, Senior Vice President - Sales & Marketing

Rod Allen is a team-oriented, successful sales and marketing leader with more than 20 years of experience in Healthcare Sales, Marketing, and Sales Education. Prior to joining Catalyst, Rod has had an impressive career in sales leadership and sales force development, recently as Vice President and General Manager of Sports Medicine | Orthopedics for RTI Biologics. At RTI, he oversaw all aspects of the company's sports medicine division, including business development, new product development, national accounts, sales, marketing and customer service. Prior to joining RTI, Rod spent many years in business development, sales and marketing in a variety of large high-tech and early-stage medical device companies, namely UUNET Technologies, medibuy.com (Global Health Exchange), and Multimedia Medical Systems.

A native of Chicago, Rod earned a bachelor's degree from Drake University and a master's degree in business administration, from the University of Maryland - College Park.

Steven S. Goldberg, M.D., Founder & Chief Medical Officer

Dr. Steven S. Goldberg is the Founder & Chief Medical Officer of Catalyst OrthoScience.  He is a board certified orthopedic surgeon and is the Chief of the Division of Orthopedic Surgery at Physicians Regional Healthcare System in Naples. He is the lead author on several research articles including the Journal of Bone and Joint Surgery, the leading journal in the orthopedic field.  He received his Bachelor of Science in Chemistry from the University of Virginia and his medical degree from Rutgers New Jersey Medical School. Dr. Goldberg completed a fellowship in Shoulder Surgery and Sports Medicine at Columbia University in New York City. Founded by Dr. Charles Neer, who is known as the “father of modern shoulder surgery,” this is the nation’s oldest and most prestigious shoulder fellowship.

Board of directors

Steven S. Goldberg, M.D.

Dr. Steven S. Goldberg is the Founder of Catalyst OrthoScience.  He is a board certified orthopedic surgeon and is the Chief of the Division of Orthopedic Surgery at Physicians Regional Healthcare System in Naples. He is the lead author on several research articles including the Journal of Bone and Joint Surgery, the leading journal in the orthopedic field.  He received his Bachelor of Science in Chemistry from the University of Virginia and his medical degree from Rutgers New Jersey Medical School. Dr. Goldberg completed a fellowship in Shoulder Surgery and Sports Medicine at Columbia University in New York City. Founded by Dr. Charles Neer, who is known as the “father of modern shoulder surgery,” this is the nation’s oldest and most prestigious shoulder fellowship.

Robert M. Kaufman

Robert M. Kaufman is the President and Chief Operating Officer of Oakley Investment, Inc., a private investment firm. He was the Senior Vice President and Chief Operating Officer of Outcome Sciences, Inc. (sold to Quintiles Transnational Holdings, Inc.). Mr. Kaufman was a founder and the Chief Executive Officer of Medeview, Inc. Mr. Kaufman also served as Chief Executive Officer of a senior housing company known as Carematrix Corp. Prior to that, he was a partner with Coopers & Lybrand, LLP primarily servicing real estate and healthcare industry clients. Mr. Kaufman received his Bachelor of Arts from Colby College and his Master of Business Administration degree from Cornell University.

Derace Schaffer, MD

Derace Schaffer, MD is the founder and Chief Executive Officer of the LAN Group, a venture capital firm specializing in healthcare and technology investments. Dr. Schaffer has either founded or co-founded more than 20 companies, both public and private, and he currently sits on the Board of Directors of three public companies in addition to Medical Tracking Solutions. He completed his postgraduate medical training at the Harvard Medical School and at Massachusetts General Hospital where he was Chief Resident. Dr. Schaffer has been a Professor at both the University of Rochester School of Medicine and the Cornell School of Medicine. He is a member of Alpha Omega Alpha, the National Medical Honor Society.

David S. Wood

David S. Wood served as the Chief Executive Officer and President at Spinal Modulation, Inc unitil its acquisition by St. Jude Medical, Inc. in May 2015. He was previously President and COO of CardioNet, and VP and General Manager of the Drug Delivery Business Unit at SurModics. Before joining SurModics, he held a variety of management positions in product development, operations, and marketing at Guidant Corporation’s Cardiac Rhythm Management Business Unit. Mr. Wood also currently serves on the Board of Directors of SpinaThera Mr. Wood received his undergraduate degree in Chemical Engineering from Vanderbilt University and an MBA from Wharton School at the University of Pennsylvania.

 

“I felt great almost immediately after surgery.
My range of motion came back much faster than I thought it would.
I should be playing golf again soon.”
– Jerry C.

 

 

Our Quality Policy

Our pledge at Catalyst OrthoScience is to deliver the highest quality medical devices that will meet or exceed the expectations of our customers, meet regulatory requirements and demonstrate our commitment to excellence. As part of this commitment, Catalyst OrthoScience will strive to continually improve the safety and efficacy of our products through an effective quality management system.